{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T17:21:18Z","timestamp":1765041678313,"version":"3.43.0"},"reference-count":0,"publisher":"Frontline Medical Communications, Inc.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,1]]},"DOI":"10.12788\/cutis.1239","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T19:11:08Z","timestamp":1754593868000},"source":"Crossref","is-referenced-by-count":1,"title":["Spironolactone for Acne: Practical Strategies for Optimal Clinical Outcomes"],"prefix":"10.12788","volume":"116","author":[{"given":"Sherry","family":"Ershadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5043","container-title":["Cutis"],"original-title":[],"link":[{"URL":"https:\/\/cdn.mdedge.com\/files\/s3fs-public\/issues\/articles\/CT116001026.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T19:11:08Z","timestamp":1754593868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdedge.com\/cutis\/article\/272626\/acne\/spironolactone-acne-practical-strategies-optimal-clinical-outcomes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,7,1]]}},"URL":"https:\/\/doi.org\/10.12788\/cutis.1239","relation":{},"subject":[],"published":{"date-parts":[[2025,7,1]]}}}